Mercado de tecnología de enzimas médicas: mapeo competitivo y perspectivas estratégicas para 2028

  • Report Code : TIPRE00020828
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 231
Buy Now

Medical Enzyme Technology Market to Grow at a CAGR of 6.7% to reach US$ 6,700.00 million from 2020 to 2028

Buy Now

 

Se espera que la tecnología de enzimas médicas alcance los US$ 6.700,00 millones en 2028 desde US$ 4.012,57 millones en 2020; Se estima que crecerá a una tasa compuesta anual del 6,7% de 2021 a 2028.

 

El mercado de tecnología de enzimas médicas se ha analizado según el tipo de enzima, la aplicación y la región. El mercado basado en la región está segmentado en América del Norte, Europa, Asia Pacífico, Oriente Medio y África, y América del Sur y Central. El informe hace hincapié en parámetros como las tendencias del mercado, los avances tecnológicos, la dinámica del mercado y el análisis del panorama competitivo de la empresa líder para ofrecer información y un análisis en profundidad del mercado de tecnología de enzimas médicas . También incluye el análisis de la pandemia de COVID-19 en todo el mercado en todas las regiones clave.

 

Perspectivas del mercado

 

 

Los avances en la ingeniería de enzimas emergerán como tendencia clave en el mercado de tecnología de enzimas médicas

 

La ingeniería enzimática juega un papel fundamental en el desarrollo de biocatalizadores eficientes para biotecnología, ciencias de la vida y biomedicina . La ingeniería enzimática es el proceso de adaptar nuevos biocatalizadores con propiedades mejoradas mediante la alteración de sus secuencias de aminoácidos. A pesar de la inmensidad de posibles alteraciones, este procedimiento ya ha arrojado resultados notables en forma de diseños únicos y optimización de enzimas para la biosíntesis química y farmacéutica, la medicina regenerativa, la producción de alimentos, la biodegradación de residuos y la biodetección .

 

Personalice la investigación para adaptarla a sus necesidades

Podemos optimizar y adaptar el análisis y el alcance que no se cumplen a través de nuestras ofertas estándar. Esta flexibilidad le ayudará a obtener la información exacta que necesita para la planificación y la toma de decisiones de su negocio.

Mercado de tecnología de enzimas médicas: ideas estratégicas

Mercado de tecnología de enzimas médicas
  • Medical Enzyme Technology Market
    CAGR (2020 - 2028)
    6,7%
  • Tamaño del mercado 2020
    US$ 4,01 mil millones
  • Tamaño del mercado 2028
    US$ 6,7 mil millones

Dinámica del mercado

CONTROLADORES DE CRECIMIENTO
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURAS TENDENCIAS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPORTUNIDADES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Jugadores claves . Jugadores principales

  •  
  • merck
  • Termo Fisher Scientific Inc.
  • Novozymes
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • Tecnologías Agilent, Inc.
  • Danaher (Cytiva)
  • sanofi
  • Corporación Asahi Kasei
  • Corporación Promega

Panorama regional

Medical Enzyme Technology Market
  • América del norte
  • Europa
  • Asia-Pacífico
  • América del Sur y Central
  • Medio Oriente y África

Segmentación de mercado

Medical Enzyme Technology MarketTipo de enzima
  • Enzimas digestivas
  • Enzimas trombolíticas
  • hidrolasas
  • endonucleasas
Medical Enzyme Technology MarketSolicitud
  • Tratamiento de enfermedades
  • Herramientas diagnosticas
  • Investigación biomédica
  • Otros
Medical Enzyme Technology MarketGeografía
  • América del norte
  • Europa
  • Asia Pacífico
  • Medio Oriente y África
  • América del Sur y Central
  • El PDF de muestra muestra la estructura del contenido y la naturaleza de la información con análisis cualitativo y cuantitativo.

 

Además del diseño racional clásico y los enfoques de evolución dirigida, los métodos de aprendizaje automático (ML) se aplican cada vez más para encontrar patrones en los datos que ayuden a predecir las estructuras de las proteínas; mejorar la estabilidad, solubilidad y función de las enzimas; predecir la especificidad del sustrato; y guiar el diseño racional de proteínas. El aprendizaje automático es un tercer enfoque para el diseño de nuevos biocatalizadores, que ha ido ganando atención desde las últimas décadas. A diferencia de los métodos de diseño racional basados ​​en modelos, esta estrategia se basa en datos, ya que identifica patrones en los datos existentes para predecir propiedades de una entrada desconocida pero similar. En enero de 2020, Curative Enzymes, un proveedor de productos y servicios, lanzó el servicio de modificación e ingeniería de enzimas para ayudar a los principales clientes.

Con la aparición de nuevas técnicas y métodos para reconstruir y diseñar enzimas, trabajar en ingeniería de proteínas se ha vuelto más conveniente, lo que ha arrojado luz sobre nuevos biocatalizadores y moléculas semisintéticos o sintéticos para aplicaciones industriales. Por lo tanto, es probable que los avances en la ingeniería de enzimas sean una tendencia predominante en el mercado durante el período de pronóstico.

 

Información basada en tipos de enzimas

 

El mercado de tecnología de enzimas médicas, por tipo de enzima, se segmenta en enzimas digestivas, enzimas trombolíticas, hidrolasas y endonucleasas. El segmento de hidrolasas tuvo la mayor participación del mercado en 2020; Además, se prevé que el segmento de enzimas trombolíticas registre la tasa compuesta anual más alta del mercado del 7,2% durante el período previsto.

 

Información basada en aplicaciones

 

El mercado de tecnología de enzimas médicas, por aplicación, se segmenta en tratamiento de enfermedades, herramientas de diagnóstico, investigación biomédica y otros. El segmento de tratamiento de enfermedades tuvo la mayor participación del mercado en 2020, y se prevé que el mismo segmento registre la CAGR más alta del 7,1% en el mercado durante el período previsto.

Las empresas que operan en el mercado de tecnología de enzimas médicas están adoptando estrategias orgánicas, como lanzamientos y expansiones de productos, para ampliar su presencia y cartera de productos en todo el mundo, así como para abordar las crecientes demandas.

 

Alcance del informe de mercado de tecnología de enzimas médicas

Atributo del informeDetalles
Tamaño del mercado en 20204.010 millones de dólares
Tamaño del mercado para 20286,7 mil millones de dólares
CAGR global (2020 - 2028)6,7%
Información histórica2018-2019
Período de pronóstico2021-2028
Segmentos cubiertosPor tipo de enzima
  • Enzimas digestivas
  • Enzimas trombolíticas
  • hidrolasas
  • endonucleasas
Por aplicación
  • Tratamiento de enfermedades
  • Herramientas diagnosticas
  • Investigación biomédica
  • Otros
Regiones y países cubiertosAmérica del norte
  • A NOSOTROS
  • Canadá
  • México
Europa
  • Reino Unido
  • Alemania
  • Francia
  • Rusia
  • Italia
  • El resto de Europa
Asia-Pacífico
  • Porcelana
  • India
  • Japón
  • Australia
  • Resto de Asia-Pacífico
América del Sur y Central
  • Brasil
  • Argentina
  • Resto de América del Sur y Central
Medio Oriente y África
  • Sudáfrica
  • Arabia Saudita
  • Emiratos Árabes Unidos
  • Resto de Medio Oriente y África
Líderes del mercado y perfiles clave de empresas
  •  
  • merck
  • Termo Fisher Scientific Inc.
  • Novozymes
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • Tecnologías Agilent, Inc.
  • Danaher (Cytiva)
  • sanofi
  • Corporación Asahi Kasei
  • Corporación Promega
  • El PDF de muestra muestra la estructura del contenido y la naturaleza de la información con análisis cualitativo y cuantitativo.

 

Por tipo de enzima

  • Enzima digestiva
  • L-asparaginasa
  • Lactasa
  • Otros
  • Enzima trombolítica
  • estreptoquinasa
  • Uroquinasa
  • Otros
  • Enzima hidrolasa
  • hialuronidasa
  • lisozimas
  • Otros
  • Enzima Endonucleasas
  • Benzonasa
  • Otros

 

Por aplicación

 

  • Tratamientos de enfermedades
  • Herramientas diagnosticas
  • Investigación biomédica
  • Otros

 

Por

Geografía

 

  • América del norte

    • A NOSOTROS
    • Canadá
    • México
  • Europa

    • Francia
    • Alemania
    • Italia
    • Reino Unido
    • España
    • El resto de Europa
  • Asia Pacífico (APAC)

    • Porcelana
    • India
    • Corea del Sur
    • Japón
    • Australia
    • Resto de Asia Pacífico
  • Medio Oriente y África (MEA)

    • Sudáfrica
    • Arabia Saudita
    • Emiratos Árabes Unidos
    • Resto de MEA
  • América del Sur y Central (SCAM)

    • Brasil
    • Argentina
    • Resto de ESTAFA

 

Perfiles de empresa

 

  • merck
  • Termo Fisher Scientific Inc.
  • Novozymes
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • Tecnologías Agilent, Inc.
  • Danaher (Cytiva)
  • sanofi
  • Corporación Asahi Kasei
  • Corporación Promega
  • Amano Enzima Inc
  • Corporación Genzyme

Medical Enzyme Technology Market Report Scope

Report Attribute Details
Market size in US$ 4.01 Billion
Market Size by US$ 6.7 Billion
Global CAGR 6.7%
Historical Data 2018-2019
Forecast period 2021-2028
Segments Covered By Tipo de enzima
  • enzimas digestivas
  • enzimas trombolíticas
  • hidrolasas y endonucleasas
By Aplicación
  • Tratamiento de Enfermedades
  • Herramientas de Diagnóstico
  • Investigación Biomédica y Otros
By Geografía
  • América del Norte
  • Europa
  • Asia Pacífico
  • Medio Oriente y África
  • América del Sur y Central
Regions and Countries Covered América del Norte
  • EE. UU.
  • Canadá
  • México
Europa
  • Reino Unido
  • Alemania
  • Francia
  • Rusia
  • Italia
  • resto de Europa
Asia-Pacífico
  • China
  • India
  • Japón
  • Australia
  • resto de Asia-Pacífico
América del Sur y Central
  • Brasil
  • Argentina
  • Resto de América del Sur y Central
Medio Oriente y África
  • Sudáfrica
  • Arabia Saudita
  • Emiratos Árabes Unidos
  • Resto de Medio Oriente y África
Market leaders and key company profiles
  • Merck
  • Thermo Fisher Scientific Inc
  • Novozymes
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • Agilent Technologies Inc
  • Danaher Cytiva
  • Sanofi
  • Asahi Kasei Corporation
  • Promega Corporation
  • Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What is the cost of Medical Enzyme Technology?

    The costs of the Medical Enzyme Technology are much higher, and they may cost US$ 5–50, or more, per enzyme type. The cost may also differ from product to product types.

    What are the driving factors for the Medical Enzyme Technology market across the globe?

    Key factors that are driving the market are advent of recombinant DNA technology, it has become possible to make formerly rare enzymes in large quantities and hence to reduce cost. Also, in pharmaceutical manufacturing, the desire to make chirally pure compounds is leading to new opportunities. Technological advances have facilitated the use of enzymes over an increasingly broad range of process conditions.

    What are Medical Enzyme Technology?

    Enzymes are proteins produced in living cells of plants, animals, and microorganisms. All living organisms require enzymes for growth and for the production and utilization of energy which is essential for life. In the living cell, enzymes act as catalysts to speed up the chemical reactions which control life processes. Enzymes have been significant industrial products for more than a hundred years. However, the range of potential applications is increasing rapidly.

    The List of Companies - Medical Enzyme Technology Market

    1. Merck
    2. Thermo Fisher Scientific Inc.
    3. Novozymes
    4. TAKEDA PHARMACEUTICAL COMPANY LIMITED
    5. Agilent Technologies, Inc.
    6. Danaher (Cytiva)
    7. Sanofi
    8. Asahi Kasei Corporation
    9. Promega Corporation
    10. Amano Enzyme Inc
    11. Genzyme Corporation

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Biotechnology : READ MORE..